Student-Based Analysis of Perception Regarding the Educational Environment Using the Dundee Ready Education Environment Measure Questionnaire at Chattagram Maa-O-Shishu Hospital Medical College, Bangladesh.

Aim: The educational environment is the most significant manifestation of the curriculum. The Dundee Ready Education Environment Measure questionnaire is the precise quantitative assessment tool for the EE for medical- and health-related professional schools.

Method: This was a cross-sectional study conducted in Chattagram Maa-O-Shishu Hospital Medical College, Chittagong, Bangladesh during the study period of 2017-2018.

Intern doctors' views on the current and future antibiotic resistance situation of Chattagram Maa O Shishu Hospital Medical College, Bangladesh.

Background: Bacterial resistance due to antibiotic misuse is reported every day. Such threat calls for a consensus to develop new strategies to prevent the development of antibiotic resistance of bacteria. Medical doctors must play a pivotal role to control and prevent the misuse of antibiotics.

Empathy in undergraduate medical students of bangladesh: psychometric analysis and differences by gender, academic year, and specialty preferences.

Empathy is considered to be associated with better patient compliance, satisfaction, and clinical outcomes. The aim of the study is to measure and examine empathy among a sample of undergraduate medical students of Bangladesh. It was a cross-sectional study and all the medical students of first through fifth year enrolled at Chattagram Maa-O-Shishu Hospital Medical College during the study period of 2014 were surveyed.

Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patients.

A prospective, open label, parallel group and randomized study was conducted to see the effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patients. 18 patients (proteinuria 2 0.5 gm/day and serum creatinine <3 mg/dL) were selected and then randomly grouped to receive enalapril (5-40 mg/day, n=10) and losartan (25-200 mg/day, n=8) in increasing dose for 16 weeks.